These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1225836)

  • 1. Urinary steroid hormone patterns: III. Effect of continuous daily administration of low dose megestrol acetate.
    Kumari GL; Roy S; Allag IS; Ghosal J
    Indian J Med Res; 1975 Dec; 63(12):1774-86. PubMed ID: 1225836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
    Zaki K; Younis N; Nour H
    Egypt Popul Fam Plann Rev; 1971 Dec; 4(2):1-5. PubMed ID: 12255961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L; Tamme E
    J Int Med Res; 1975; 3(2):63-72. PubMed ID: 1140508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 2. Maintenance of ovarian function in patients with megestrol acetate implants.
    Benagiano G; Ermini M; Carenza L; Donini P
    Acta Endocrinol (Copenh); 1973 Jun; 73(2):347-59. PubMed ID: 4740834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and plasma lipids.
    Dhillon MK; Sarkar AK; Gupta AN; Devi PK
    J Obstet Gynaecol India; 1972; 22(6):622-6. PubMed ID: 12332899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulation inhibition with sequential therapy. A continuing clinical study of fertility control.
    Suran RR
    Fertil Steril; 1967; 18(5):598-615. PubMed ID: 6037449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Anovlar in gynaecological disorders and contraception.
    Shahani SM; Chiklikar A
    J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
    Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
    Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megestrol acetate concentrations in plasma and milk during administration of an oral contraceptive containing 4 mg megestrol acetate to nursing women.
    Nilsson S; Nygren KG; Johansson ED
    Contraception; 1977 Dec; 16(6):615-24. PubMed ID: 606501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels.
    Elstein M; Briston PG; Hewitt KJ; Kirk D; Miller H
    Br J Obstet Gynaecol; 1976 Feb; 83(2):165-8. PubMed ID: 1032819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate and lipid studies during six months' treatment with megestrol acetate. Measurements of blood glucose, insulin, growth hormone, and triglycerides.
    Spellacy WN; Newton RE; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1973 Aug; 116(8):1074-8. PubMed ID: 4721135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.